Clinical Trial Results:
An Open Label, Randomised, Parallel Group, Multicentre Study to
Compare ZOLADEX™ 10.8 mg Given Every 12 Weeks with ZOLADEX
3.6 mg Given Every 4 Weeks in Pre-menopausal Women with Oestrogen
Receptor Positive Advanced Breast Cancer
Summary
|
|
EudraCT number |
2005-004001-29 |
Trial protocol |
CZ IT |
Global completion date |
18 Nov 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Sep 2016
|
First version publication date |
03 Sep 2016
|
Other versions |
|
Summary report(s) |
CSRsynopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.